“Thank you so much for the updates! These data are really important to guide our next step and thank you so much for delivering the results so quickly. We are very impressed with your work! Thank you again!”
Associate Professor, Californian University, May 2024
“The service I received during the course of my project was excellent. I am very happy with the outcome, and I trust the results and interpretation from your highly skilled team. I would absolutely utilize Gifford Bioscience again for future projects.”
Director Laboratory Ops, New Jersey Biotech, Apr 2024
“The service was excellent. Maintain this approach.
I would recommend Gifford. Informed discussion prior to initiation of the project coupled with clarity of expectations, and regular updates of progress, all made for an excellent service.”
Senior Scientist, UK Research Institute, Oct 2023
“I’m very satisfied. We get data back very fast, the scientists we work with communicate clear knowledge of our assay design and goals, provide assistance with assay development, and return quality final reports. “
Scientist, Californian Biotech, Oct 2023
An international customer base:
50% of our clients are in the USA. A further quarter are based in the EU.
(2021-23)
“Thank you for a very well executed study and a high quality report which you delivered efficiently, we do appreciate it.”
Senior Director of Research, Californian Pharma, Apr 2023
88% of our business is repeat business, coming from the scientists we have worked with before.
(2021-23)
“The service was very good, turnaround time was very efficient and the data were well presented. In particular, the communication with Kevin and Becky was very clear. We would definitely recommend your services to others.”
CTO, UK Biotech, Apr 2023
“I would like thank you, Macer, Sian and your Team for the extremely fast and excellent work. We appreciate it a lot. The data and report are all clear.”
Scientist, Swiss Life Sciences Institute, Jan 2023
“Your service has been great – good communications – skilled scientists- quality data and presentations ;O).”
Principal Scientist, Big Pharma, Denmark, Dec 2022
“Excellent work, high quality, very thorough and diligent. Love working with Gifford.”
Director Biology, Californian Biotech, Aug 2022
“We particularly appreciate the way your experienced scientists engage in scientific discourse with us, ensuring the optimal use of radioligand binding assays. Grateful for the excellent overall service.”
Associate Professor, East Coast University School of Medicine, Aug 2022
“We are so impressed with your serious scientific discussion, professional advice, and excellent service. We would like to commission many experiments with our other pipeline in the future, and I promise to introduce Gifford to many other groups. Thanks to all of you!”
Principal Researcher, Korean Biotech, 2021
“I am really impressed how fast and professionally you act. 😊. It is clear to me that you at Gifford like ‘doing science’ and challenges.”
Principal Scientist, German Pharma, 2021
“Our group discussed your initial KOR binding data in our meeting today. All were very impressed with the quality of your data.”
Board Member, Boston Biotech, 2021
Contact Us
This site is protected by reCAPTCHA. The information you supply will be processed in accordance with the General Data Protection Regulation (EU & UK). For further details, please refer to our Privacy Policy.
Copyright © 2024 Gifford Bioscience Limited
Privacy Policy